Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 29 studies | 58% ± 23% | |
smooth muscle cell | 28 studies | 51% ± 22% | |
fibroblast | 21 studies | 37% ± 16% | |
oligodendrocyte | 16 studies | 43% ± 16% | |
endothelial cell | 16 studies | 29% ± 13% | |
plasmacytoid dendritic cell | 15 studies | 29% ± 9% | |
connective tissue cell | 11 studies | 35% ± 16% | |
B cell | 10 studies | 29% ± 9% | |
endothelial cell of artery | 8 studies | 30% ± 13% | |
myofibroblast cell | 8 studies | 34% ± 12% | |
capillary endothelial cell | 7 studies | 32% ± 9% | |
platelet | 6 studies | 29% ± 6% | |
conventional dendritic cell | 6 studies | 27% ± 11% | |
dendritic cell | 5 studies | 35% ± 7% | |
precursor B cell | 4 studies | 41% ± 15% | |
immature B cell | 4 studies | 42% ± 23% | |
memory B cell | 4 studies | 19% ± 2% | |
glomerular endothelial cell | 3 studies | 27% ± 5% | |
epithelial cell | 3 studies | 26% ± 13% | |
muscle cell | 3 studies | 45% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 95% | 3430.84 | 171 / 180 | 98% | 57.94 | 420 / 430 |
adrenal gland | 98% | 4014.61 | 253 / 258 | 89% | 62.78 | 205 / 230 |
prostate | 81% | 3673.93 | 198 / 245 | 96% | 34.46 | 483 / 502 |
lung | 96% | 4619.86 | 557 / 578 | 79% | 16.83 | 918 / 1155 |
bladder | 86% | 7987.81 | 18 / 21 | 79% | 17.21 | 397 / 504 |
intestine | 75% | 6680.55 | 726 / 966 | 80% | 14.39 | 421 / 527 |
brain | 58% | 2890.70 | 1521 / 2642 | 97% | 55.16 | 684 / 705 |
uterus | 94% | 5377.50 | 160 / 170 | 57% | 21.20 | 260 / 459 |
esophagus | 71% | 7423.87 | 1033 / 1445 | 79% | 13.98 | 145 / 183 |
breast | 87% | 2982.61 | 399 / 459 | 47% | 7.59 | 527 / 1118 |
stomach | 44% | 2957.48 | 158 / 359 | 83% | 22.73 | 237 / 286 |
kidney | 38% | 882.35 | 34 / 89 | 66% | 14.23 | 594 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.12 | 1 / 1 |
blood vessel | 100% | 28054.31 | 1332 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 1% | 23.20 | 4 / 328 | 96% | 26.46 | 171 / 178 |
spleen | 86% | 2787.48 | 207 / 241 | 0% | 0 | 0 / 0 |
adipose | 86% | 3318.06 | 1034 / 1204 | 0% | 0 | 0 / 0 |
liver | 2% | 33.42 | 4 / 226 | 65% | 8.97 | 265 / 406 |
thymus | 10% | 272.86 | 66 / 653 | 53% | 5.84 | 319 / 605 |
heart | 31% | 600.00 | 269 / 861 | 0% | 0 | 0 / 0 |
skin | 8% | 154.59 | 138 / 1809 | 17% | 1.92 | 82 / 472 |
lymph node | 0% | 0 | 0 / 0 | 24% | 6.51 | 7 / 29 |
tonsil | 0% | 0 | 0 / 0 | 20% | 1.57 | 9 / 45 |
muscle | 3% | 58.29 | 22 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.15 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042325 | Biological process | regulation of phosphorylation |
GO_0005829 | Cellular component | cytosol |
GO_0004865 | Molecular function | protein serine/threonine phosphatase inhibitor activity |
Gene name | PPP1R14A |
Protein name | Protein phosphatase 1 regulatory subunit 14 Protein phosphatase 1 regulatory subunit 14A (17 kDa PKC-potentiated inhibitory protein of PP1) (Protein kinase C-potentiated inhibitor protein of 17 kDa) (CPI-17) |
Synonyms | CPI17 PPP1INL |
Description | FUNCTION: Inhibitor of PPP1CA. Has over 1000-fold higher inhibitory activity when phosphorylated, creating a molecular switch for regulating the phosphorylation status of PPP1CA substrates and smooth muscle contraction. FUNCTION: Inhibitor of PPP1CA. . FUNCTION: Inhibitor of PPP1CA. . FUNCTION: Inhibitor of PPP1CA. . |
Accessions | ENST00000591291.5 ENST00000301242.9 [Q96A00-1] ENST00000347262.8 [Q96A00-2] K7EMN0 ENST00000587515.5 Q96A00 A0A0B4J2A3 ENST00000591585.1 K7EJB8 |